3
Views
5
CrossRef citations to date
0
Altmetric
Research Article

A Clinical Study of Secretin in Autism and Pervasive Developmental Delay

&
Pages 271-280 | Published online: 13 Jul 2009

  • Horvath K, Stefanatos G, Sololski K N et al. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 1998; 9(1): 9-15.
  • Perry R, Bangaru B S. Secretin in autism. J Child Adolesc Psychopharmacol 1998; 8: 247-8.
  • Edelson S, Cantor D. Autism: xenobiotic influences. Toxicol Ind Health 1998; 14(4): 553-63.
  • Edelson S, Cantor D. Autism: xenobiotic influences. Toxicol Ind Health 1998; 14(6): 799-811.
  • Marlowe M, Errera J, Jacobs J. Increased lead and cadmium burdens among mentally retarded children and children with borderline intelligence. Am J Ment Def 1983; 87(5): 477-83.
  • Marlowe M, Cossairt A, Welch K, Errera J. Hair mineral content as a predictor of learning disabilities. J Learning Disabilities 1984; 17(7): 418-21.
  • Marlowe M, Jacobs J, Moon C, Errera J. Main and interaction effects of metal pollutants in emotionally disturbed children.. In: Rutherford R B, (ed.) Monograph in Behavioral Disorders, Vol 7. Reston, VA: Council for Children with Behavioral Disorders, 1984: 67-79.
  • Marlowe M, Stellern J, Moon C, Errera J. Main and interaction effects of metallic toxins in aggressive classroom behavior. Aggressive Behavior 1985; 11: 41-8.
  • Moon C, Marlowe M. Hair-aluminum concentrations and childrens' classroom behavior. Biol Trace Elem Res 1986; 11: 5-12.
  • Hincke MT, Demaille JG. Calmodulin regulation of the ATP-dependent calcium uptake by inverted vesicles prepared from rabbit synaptosomal plasma membranes. Biochem Biophys Acta 1984; 771(2): 188-94.
  • Farnell BJ, Crapper DR, McLachlan DR, Bainbridge K et al. Calcium metabolism in aluminum encephalopathy. Exp Neurol 1985; 88: 68-83.
  • Flaten TP, Alfrey AC, Birchall JD et al. Status and future concerns of clinical and environmental aluminum toxicology. J Toxicol Env Health 1996; 48: 527-41.
  • Endohazi M, Newman RL. Aluminum hydroxide granuloma. BMJ 1971; 3(775): 621-3.
  • Gruskin AB. Aluminum: a pediatric overview Adv Pediatr 1988; 35: 281- 330.
  • Exley C, Burgess E, Day JP. Aluminum toxicokinetics. J Toxicol Env Health 1996; 48: 569-84.
  • Tuthill RW. Hair lead levels related to childrens' classroom attention-deficit behavior. Arch Env Health 1996; 51: 214-20.
  • Shearer TR, Larsen K. Minerals in the hair and nutrient intake of autistic children. J Autism Dev Dis 1982; 12: 25-35.
  • Gentile PS, Coleman M. Brief report: trace elements in the hair of autistic children. J Autism Dev Dis 1983;13: 205-6.
  • Wakefield AJ, Murch SH, Anthony A et al. Ileal-lymphoid-nodular hyperplasia, non specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41.
  • Taylor B, Miller E, Farrington P, et al. Autism and measles, mu mps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026-9.
  • Sabra A, Bellanti JA, Colon AR. Ileal-lymphoid hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 1998; 352: 234-5.
  • Conners SL, Crowell DE. Secretin and autism: the role of cysteine (letter). J Am Acad Child Adolesc Psychiat 1999; 38(7): 795-6.
  • Ho PK, Fong RS, Kai HS et al. The human secretin receptor gene: genomic organization and promoter characterization. FEBS Lett 1999; 455(3): 209-14.
  • Babaraczy E, Szabo G, Telegady G. Effects of secretin on acute and chronic effects of morphine. Pharmacol Biochem Behav 1995; 51: 469-72.
  • Charlton CG. Secretin modulation of behavioral and physiological functions in the rat. Peptides 1983; 4(5): 739-42.
  • Sandler AD, Sutton KA, DeWeese J et al. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med 1999; 341: 1801-6.
  • Horvath K, Papadimitriou JC, Robaztyn A et al. Gastrointestinal abnormalities in children with autistic disorder. J Pediat 1999; 135: 559-63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.